Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes
Abstract
Share and Cite
Ludwiniak, K.; Olejnik, P.; Maciejewska, O.; Opuchlik, A.; Małyszko, J.; Golenia, A. Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. J. Clin. Med. 2026, 15, 562. https://doi.org/10.3390/jcm15020562
Ludwiniak K, Olejnik P, Maciejewska O, Opuchlik A, Małyszko J, Golenia A. Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. Journal of Clinical Medicine. 2026; 15(2):562. https://doi.org/10.3390/jcm15020562
Chicago/Turabian StyleLudwiniak, Kamil, Piotr Olejnik, Oliwia Maciejewska, Andrzej Opuchlik, Jolanta Małyszko, and Aleksandra Golenia. 2026. "Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes" Journal of Clinical Medicine 15, no. 2: 562. https://doi.org/10.3390/jcm15020562
APA StyleLudwiniak, K., Olejnik, P., Maciejewska, O., Opuchlik, A., Małyszko, J., & Golenia, A. (2026). Admission eGFR as a Marker of Systemic Vulnerability in Patients with Spontaneous Intracerebral Hemorrhage: Impact of Premorbid Disability and Acute Kidney Injury on Outcomes. Journal of Clinical Medicine, 15(2), 562. https://doi.org/10.3390/jcm15020562

